EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Overcoming Methodological Challenges for Advancing Stem Cell Therapies in Parkinson’s Disease

Stephen Polgar, David I Finkelstein, Leila Karimi iD

Cell Transplantation · 2024

DOI: 10.1177/09636897241246355 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cell Transplantation, 2024. Verfasst von Stephen Polgar und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Health and Biomedical Sciences, RMIT University, Melbourne, VIC, Australia. Hauptthemen laut MEDLINE: Fetal Stem Cells, Parkinson Disease. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The quest for new and improved therapies for Parkinson’s disease (PD) remains of paramount importance, despite previous trial failures. There is a current debate regarding the potential of stem cell research as a therapeutic approach for PD. The studies of dopaminergic fetal stem cells for PD treatment, their design, and the results of the initial surgical placebo-controlled trials were reviewed in this study. Some of the fundamental methodological challenges and possible strategies to resolve them were proposed. In this article, we argue that the most important impact lies in the proof-of-principle demonstrated by clinical trials for cell replacement strategies in reconstructing the human brain. While some researchers argue that the considerable technical challenges associated with cell therapies for PD warrant the discontinuation of further development using stem cells, we believe that the opposing viewpoints are instrumental in identifying a series of methodological misunderstandings. Here, we propose to expose key challenges to ensure the advancement of the field and unlock the potential of stem cell therapies in PD treatment. Overall, this review underscores the need for further research and innovation to overcome the hurdles in realizing the potential of stem cell–based therapies for PD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fetal Stem CellsParkinson DiseaseHumansCell- and Tissue-Based TherapyDopaminergic NeuronsStem Cell TransplantationControlled Clinical Trials as Topic

Stichwörter der Autor:innen

Parkinson’s diseasemethodological challengessham surgerystem cell therapytreatment algorithm

Autor:innen und Institutionen

  • School of Health and Biomedical Sciences, RMIT University, Melbourne, VIC, Australia.
  • University of Melbourne, Florey Institute of Neuroscience and Mental Health, Parkville, VIC, Australia.
  • School of Medicine and Healthcare Management, Caucasus University, Tbilisi, Georgia.

ORCID-Profile: Leila Karimi

Zitieren

APA

Polgar, S., Finkelstein, D. I., & Karimi, L. (2024). Overcoming Methodological Challenges for Advancing Stem Cell Therapies in Parkinson’s Disease. Cell Transplantation. https://doi.org/10.1177/09636897241246355

Vancouver

Polgar S, Finkelstein DI, Karimi L. Overcoming Methodological Challenges for Advancing Stem Cell Therapies in Parkinson’s Disease. Cell Transplantation. 2024. doi:10.1177/09636897241246355

BibTeX
@article{Polgar2024,
  author = {Polgar, Stephen and Finkelstein, David I and Karimi, Leila},
  title = {Overcoming Methodological Challenges for Advancing Stem Cell Therapies in Parkinson’s Disease},
  journal = {Cell Transplantation},
  year = {2024},
  doi = {10.1177/09636897241246355}
}
Kostenlos starten →